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ORIGINAL ARTICLE
Completion of Baseline Trachoma Mapping in Malawi: Results of Eight
Population-Based Prevalence Surveys Conducted with the Global Trachoma
Mapping Project
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fDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
ABSTRACT
Purpose: Following a first phase of trachoma mapping in Malawi with the Global Trachoma
Mapping Project, we identified and mapped trachoma districts previously suspected to be non-
endemic, although adjacent to districts with estimated trachoma prevalences indicating a public
health problem.
Methods: We conducted population-based surveys in eight evaluation units (EUs) comprising
eight districts in Malawi (total population 3,230,272). A 2-stage cluster random sampling design
allowed us to select 30 households from each of 30 clusters per EU; all residents aged 1 year and
older in selected households were examined for evidence of trachomatous inflammation–follicular
(TF) and trachomatous trichiasis (TT).
Results: None of the eight EUs had a TF prevalence in 1–9-year-olds ≥10%, one district (Dedza)
had a TF prevalence between 5.0% and 9.9%, and only one district (Karonga) had a trichiasis
prevalence in adults ≥0.2%.
Conclusion: The prevalence of TF and TT in six of eight EUs surveyed was consistent with an
original categorization of trachoma being unlikely to be a public health problem. In the absence
of formal surveys, health management information system data and other locally available
information about trachoma is likely to be useful in predicting areas where public health inter-
ventions against trachoma are required.
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Introduction
The clinical features of trachoma, an infectious and poten-
tially blinding eye disease caused by the bacterium
Chlamydia trachomatis, are fully described elsewhere1–4
and are not the focus of this article. Previous findings by
Kalua and colleagues5,6 demonstrate that trachoma affects a
substantial number of people in Malawi, although the pro-
blem is not as bad as it is in other endemic populations.7
As part of the Global Trachoma Mapping Project
(GTMP), all 17 suspected trachoma-endemic districts of
Malawi were mapped between 2013 and 2014, and those
confirmed as having trachoma as a public health problem
have now started to implement the SAFE (Surgery,
Antibiotics, Facial cleanliness, and Environmental
improvement) strategy and are progressing well, with
Malawi targeting to eliminate trachoma as a public health
problem by 2019. A total of 11 remaining districts (five in
the Northern Region, one in the Central Region, and five in
the Southern Region), were notmapped in phase one of the
GTMP in Malawi, based on data collected by the heath
management information systems and other anecdotal
information suggesting that trachoma was unlikely to
represent a public health problem in these districts.
Following completion of phase one mapping, however,
Malawi Ministry of Health officials were able to consider
trachoma prevalence in phase one districts and trachoma
prevalence in bordering districts of Zambia, Tanzania, and
Mozambique, and consensus was reached that mapping
was needed in eight of the previously unsuspected districts
(five Northern, one Central, and two Southern) of Malawi.
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The remaining three districts still lacked a rationale to
undertake population-based prevalence surveys of
trachoma.
With support from the GTMP, we set out to map
these eight districts, in order to complete baseline tra-
choma mapping in Malawi.
Materials and methods
Approval was obtained from the National Health Sciences
Research Committee of Malawi, and from the district
health administrative offices. Approval for the GTMP in
its entirety was obtained from the ethics committee of the
London School of Hygiene & Tropical Medicine (refer-
ence 6319). Upon explanation of the purpose of the study,
written informed consent was obtained from all subjects
who participated in the study. Where the participant was
a minor, informed consent was obtained from the head of
household or guardian.
The study was a series of cross-sectional population-
based surveys designed to obtain district level preva-
lence estimates of trachomatous inflammation–follicu-
lar (TF) in children aged 1–9 years, and trichiasis in
persons aged 15 years and older. The study was con-
ducted between May 2014 and July 2015. We used the
GTMP standardized training package and methodolo-
gies, as described previously.8 The Malawian team lea-
der (KK), who was a GTMP Master Grader, conducted
a 3-day field practice refresher course for graders, all of
whom had been GTMP-certified in 2013.5,6
Sample size
As described elsewhere,8 the GTMP sample size in each
evaluation unit is based on an expected TF prevalence in
1–9-year-olds of 10%, since this is themost critical thresh-
old for programmatic decision making. Evaluation units
in which the baseline TF prevalence in 1–9-year-olds is
10% or higher qualify for annual single-dose azithromycin
treatment of the entire population for at least 3 years,
whereas those with a TF prevalence in 1–9-year-olds
<10% do not. According to the single population propor-
tion for precision formula, if the expected TF prevalence is
10% andwewish to have 95% confidence of estimating the
true prevalence with absolute precision of 3%, 384 chil-
dren aged 1–9 years selected by simple random sampling
would be required. Assuming a cluster size of 50 children,
the design effect is estimated at 2.65 (based on previous
trachoma prevalence surveys), so 1019 children are
needed. Inflating this figure by a factor of 1.2 to account
for nonresponse, we sampled a sufficient number of
households in each evaluation unit for 1222 children
aged 1–9 years to be resident therein. Using 30 clusters
of 30 households each (based on the number of house-
holds that a team should be able to complete in a day), and
assuming there are 1.4Malawian children aged <9 years in
each household, this sample size is achieved. Although we
also aim to estimate trachomatous trichiasis (TT) preva-
lence in adults aged 15 years and older, sample sizes have
been calculated based only on parameters relating to TF in
children; the low prevalence of TT (nearly always <0.2% in
adults except in themost hyper endemic areas)means that
accurately estimating its prevalence requires substantially
larger samples. Having determined the number of house-
holds required to recruit sufficient children to estimate TF
prevalence as above, the sample of adults aged 15 years
and older used for estimating TT prevalence is set as the
adults living in those same households.We accept the loss
of precision in the estimate of TT prevalence inherent in
this approach.
Selection of clusters, households and individuals
In the first sampling stage, clusters were defined as vil-
lages, which in rural Malawi have a mean population of
1000–2000 residents. In each evaluation unit, a sampling
frame of all villages was obtained from the district health
office, and 30 were selected with probability proportional
to size. In the second sampling stage, in each selected
cluster, all head of households from the entire cluster were
pre-listed by a community health care worker, and 30 of
these were selected by matching the list with 30 pre-
selected numbers using computer-generated random
numbers. All residents of selected households aged 1
year and older were invited to participate.
Field methods
Each selected cluster was visited a few days in advance
of the survey date by a community health worker
(“Health Surveillance Assistant”) from the Ministry of
Health; this cadre is normally responsible for disease
surveillance and health promotion. Their role here was
to brief the village chief and community members and
organize the selected village household list to be used
for random household selection by the survey team.
Upon arrival in the villages, the survey team made a
random selection of households. Teams then went
house-to-house; after obtaining consent from the
household head, global positioning system and water,
sanitation and hygiene (WASH) data were collected,8
and household members were enumerated and exam-
ined for signs of trachoma, using a 2.5× magnifying
loupe (Binomag, Texas/Oklahoma, USA). Individuals
found to have active trachoma were offered two tubes
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of 1% tetracycline eye ointment and adults with trichia-
sis were referred to the district hospital.
Quality control
The 10 teamswere supervised by two supervisors, with each
team being accompanied by a supervisor for one in every
five field days. Supervisors were experienced ophthalmic
clinical officers who had been trained and GTMP-certified
as grader trainers and were part of the training team. In
addition, at the completion of fieldwork for each evaluation
unit, investigators, supervisors and recordersmet to discuss
logistical challenges faced and suggest solutions and
improvements.
Data management, analysis and reporting
Field data collection was performed using Android smart-
phones running the LINKS application system (Task
Force for Global Health, Decatur, GA, USA).9 Upon com-
pletion of field work each day, the recorder uploaded
survey data from the Android smartphone over an
encrypted connection to the GTMP secure server running
in the Amazon.com Elastic Cloud (AWS EC2).
Results
Figure 1 is a map of all districts in Malawi. A total of
240 clusters from eight evaluation units (districts) were
visited, and 27,765 residents examined, of whom 10,505
(37.8%) were children aged 1–9 years, 4092 (14.7%)
were children aged 10–14 years, and 13,168 (47.4%)
were adults aged over 15 years (Table 1).
The list of districts that were previously suspected
not to have trachoma at levels indicative of a public
health problem is shown in Table 2, and the data from
the mapping exercise described here are shown in
Table 3.
For TF, except for Dedza in the Central Region
(which had a TF prevalence in 1–9-year-olds of 6.3%),
all eight districts mapped in phase two had TF preva-
lences <5%, indicating that active trachoma was not
present at levels suggesting a public health problem.
For trichiasis, in the phase two districts, only
Karonga in the far north of the country had a preva-
lence in adults above the threshold (≥0.2%) defined as
representing a public health problem.10,11 Note that
there was no justification for mapping of Blantyre,
Thyolo, and Chirazulu, which therefore remain cate-
gorized as “suspected non-endemic” districts. Of 28
districts in Malawi, these are the only three that have
now not been mapped.
Figure 2 is the updated baseline prevalence map for
TF in Malawi, according to the most recent survey data,
including those reported in the current manuscript. As
can be readily seen, the TF prevalence in each district in
Northern Malawi is below 5%.
Figure 3 shows the updated prevalence of trichiasis
in Malawi, according to the most recent survey data,
including those reported in the current manuscript.
District-level prevalences of WASH access variables
are not presented here, as these need much more
detailed analysis, and will be considered separately.
Discussion
Using the GTMP methodology, we set out to generate
prevalence data on TF and trichiasis in districts that
were previously suspected not to have trachoma as a
public health problem, but which bordered districts in
Malawi and adjacent countries that had relatively high
Figure 1. Map of Malawi showing regions and districts.
Table 1. Sex distribution of examined individuals, Global
Trachoma Mapping Project, Malawi phase two, 2014–2015.
Sex Total, n (%)
Children 1–9 years,
n (%)
Adults 15+ years,
n (%)
Male 12,633 (45.50) 5230 (49.79) 5440 (41.31)
Female 15,132 (54.50) 5275 (50.11) 7728 (58.69)
Total 27,765 (100) 10,505 (100) 13,168 (100)
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burdens of trachoma. This has enabled us to complete
the baseline trachoma map for Malawi, as part of the
broader effort to finalize mapping of trachoma
globally.7,12 A more important domestic outcome is
the contribution that these data will now make to
guiding national policy and decision-making in regards
to implementation of the SAFE strategy for trachoma
elimination. Hearteningly, our data show that only two
of the evaluation units mapped in phase two had
either trichiasis or TF at levels warranting public
health concern. One of those districts was Karonga,
where the TF prevalence was <5% but the trichiasis
prevalence was 0.2%. Karonga district borders Mbeya
region of Tanzania, which has a moderately high pre-
valence of trichiasis.19 It was initially hypothesized
that perhaps the individuals with trichiasis seen in
our Karonga survey were there as a result of migration
of people with pre-existing cicatricial disease from
across the shared border with Tanzania, rather than
representing home-grown cases of trichiasis. However,
some of the affected communities in Karonga are
located quite some distance from the Tanzanian bor-
der, and travel between those communities and
Tanzania is reportedly rare, seemingly making the
issue of cross-border movement an unlikely explana-
tion for the trichiasis cases that we found.
The only way to (circumstantially) confirm that tri-
chiasis is likely to be trachomatous is to record the
presence of trachomatous conjunctival scarring in the
affected eye or eyes, because conjunctival scarring is a
precursor to TT. Unfortunately, the presence or
absence of conjunctival scarring was not recorded in
Table 2. List of all districts in Malawi not mapped for trachoma prior to May 2014, and action taken, Global Trachoma Mapping
Project, Malawi phase two, 2014–2015.
Region District Populationa, N Additional information received Action taken
North 1. Mzimba north 261,332 Adjacent to Zambia districts with TF >10% Changed to suspected endemic and
mapped
2. Mzimba south 572,079 Borders Kasungu, which had TF >10% Changed to suspected endemic and
mapped
3. Nkhatabay and
Likomab
251,477 Adjacent to Malawi district with TF >10% Changed to suspected endemic and
mapped
4. Rumphi 197,200 Adjacent to Zambia districts with TF >10% Changed to suspected endemic and
mapped
5. Karonga 318,098 Adjacent to Tanzania districts with TF >10% Changed to suspected endemic and
mapped
6. Chitipa 208,815 Adjacent to Tanzania districts with TF >10% Changed to suspected endemic and
mapped
Central 7. Dedza 727,396 Adjacent to Malawi and Mozambique districts with TF >10% Changed to suspected endemic and
mapped
South 8. Mulanje 612,699 Adjacent to Mozambique districts with TF >10% Changed to suspected endemic and
mapped
9. Blantyre 1,040,652 Not adjacent to any district in which trachoma is a public health
problem
Suspected non-endemic; not mapped
10. Thyolo 658,085 Not adjacent to any district in which trachoma is a public health
problem
Suspected non-endemic; not mapped
11. Chirazulu 339,271 Not adjacent to any district in which trachoma is a public health
problem
Suspected non-endemic; not mapped
aCalculated based on projections from 2008 census figures.16
bLikoma is an island with a resident population of 11,859; it was mapped in an evaluation unit with Nkhatabay rather than as a separate evaluation unit, even
though it is administratively recognized as a separate district.
TF, trachomatous inflammation–follicular.
Table 3. Prevalences of trachomatous inflammation–follicular (TF) in 1–9-year-old children, and trichiasis in the whole population,
Global Trachoma Mapping Project, Malawi phase two, 2014–2015.
Region District
TF in children 1–9 years, %
(95% CI)
Trichiasis in population/1000,
(95% CI) Final status after mapping
North 1. Mzimba north 1.6 (0.3–3.2) 0.9 (0.1–2.2) Trachoma not a public health problem
2. Mzimba south 4.3 (2.4–6.8) 0.7 (0.2–1.5) Trachoma not a public health problem
3. Nkhatabay and Likomaa 2.8 (1.1–4.6) 0.7 (0.2–1.3) Trachoma not a public health problem
4. Rumphi 2.1 (1.1–3.3) 0.6 (0.1–1.3) Trachoma not a public health problem
5. Karonga 4.1 (2.6–6.2) 2.2 (1.2–3.3) Trichiasis above threshold for elimination
6. Chitipa 1.4 (0.3–2.7) 0.0 (0.0–0.4) Trachoma not a public health problem
Central 7. Dedza 6.3 (4.5–8.6) 0.0 (0.0–0.4) TF above threshold for elimination
South 8. Mulanje 2.1 (0.8–3.9) 0.0 (0.0–0.0) Trachoma not a public health problem
aLikoma is an island with a resident population of 11,859. It was mapped in an evaluation unit with Nkhatabay rather than as a separate evaluation unit, even
though it is administratively recognized as a separate district.
Bold text: needs program intervention.
CI, confidence interval.
OPHTHALMIC EPIDEMIOLOGY 35
the first six districts surveyed here; in the same way that
these data have not formed part of the definition of
“trachomatous trichiasis” in other trachoma surveys
conducted in Malawi and elsewhere, as part of the
GTMP and outside that effort. Data on the presence
or absence of scarring were collected in the remaining
two districts of Malawi (Dedza and Mulanje), but tri-
chiasis was not frequently found there, so we are unable
to say very much about the relationship between con-
junctival scarring and trichiasis in Malawi.
If effort is expended to ensure that as many individuals
with trichiasis as possible are identified and offered surgery,
Karonga District may be able to reduce its trichiasis pre-
valence to less than 0.2% in adultswithin a short time, as the
current backlog, estimated at 800 cases, is realistically not
very high. One surgeon can comfortably operate on up to
10–20 cases per week, and could clear the entire backlog
within 2 years. There is currently no justification for mass
treatment with azithromycin in Karonga, nor for specific
measures to implement the F and E components of the
SAFE strategy for the purposes of fulfilling a trachoma
elimination agenda.13–15
Similar to nine evaluation units mapped as part of
GTMP Malawi phase one,5 Dedza in phase two had a TF
prevalence in 1–9-year-olds between 5.0% and 9.9%. This
was not too surprising, given that this district is bordered by
LilongweWest, Ntcheu, andMangochi, each of which have
estimated TF prevalences between 5.0% and 9.9%.5
Recommendations for such districts have now changed;
sub-district level mapping is no longer advocated. Instead,
a single round of azithromycinmass drug administration is
suggested, together with implementation of the F and E
components of the SAFE strategy, followed by an early
impact survey.
Of the three remaining unmapped districts (Blantyre,
Thyolo, and Chirazulu), we believe we may say with some
confidence that it is unlikely that they harbor trachoma at
levels posing a threat to public health. Blantyre is a major
commercial hub for Malawi and has a largely urban, afflu-
ent population, while Thyolo and Chirazulu have very cold
weather and contain large farms where irrigation is prac-
ticed, so access to water is generally not a challenge. We
therefore donot believe that an attempt tomap trachoma in
these remaining districts would be worthwhile from a
resource allocation perspective. For countries that are still
to complete baseline trachomamapping, this study suggests
that normal data collected using the routine heathmanage-
ment information systems, supplemented by other locally
available clues, can inform decisions on whether and where
mapping should be done.
Figure 2. Prevalence of trachomatous inflammation–follicular
(TF), Malawi.
Figure 3. Prevalence of trichiasis, Malawi.
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Now that mapping is complete in Malawi and there are
no new districts likely to require 3 years of interventions
with SAFE prior to undertaking impact surveys, Malawi is
in a much better position to accelerate its current control
efforts and eliminate trachoma ahead of the year 2020
international goal.16,17 It is left to the Ministry of Health
and supporting partners in Malawi to ensure that all those
currently at risk of trachoma blindness are attended to with
the utmost urgency.
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